Telix Pharmaceuticals Limited American Depositary Shares TLX
$11.83
-7.79%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | FORM 4 | 2026-09-14 | View → |
| 6-K | 6-K | 2026-09-14 | View → |
| 6-K | 6-K | 2026-09-02 | View → |
| 6-K | 6-K | 2026-09-01 | View → |
| 6-K | 6-K | 2026-08-20 | View → |
| 6-K | 6-K | 2026-07-21 | View → |
| 6-K | 6-K | 2026-07-02 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-05-21 | View → |
| 4 | FORM 4 | 2026-05-06 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-04-23 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-04-21 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-04-20 | View → |
| 6-K | 6-K | 2026-04-14 | View → |
| 6-K | 6-K | 2026-04-14 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-04-13 | View → |
| 6-K | 6-K | 2026-04-10 | View → |
| 6-K | 6-K | 2026-04-09 | View → |
| 6-K | 6-K | 2026-04-07 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-04-02 | View → |
| 4 | FORM 4 | 2026-04-01 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-03-16 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-03-10 | View → |
| 20-F | 20-F | 2026-02-20 | View → |
| 6-K | 6-K | 2026-02-19 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-02-18 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-02-03 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-01-20 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2026-01-12 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-12-22 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-12-17 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-12-08 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-10-14 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-09-23 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-09-09 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-08-28 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-08-21 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-07-22 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-07-09 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-06-11 | View → |
| 6-K | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 2025-05-21 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $11.83
- Market Cap
- $4.02 billion
- 52-Week Range
- $6.28 – $13.11
- Average Volume
- 238K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.